News from MarketWatch Top Stories

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Ceo Tariffs Stocks Investors Crypto Assets Cryptocurrency Shares Stock Stock Market Ethereum Price Markets Xrp Investment Blockchain Sec Stablecoin Etf Eth Bse Trade Index Ipo Earnings Solana Revenue China Coinbase Inflation Token Wall Street Nasdaq Interest Rates Sensex Usd Trade War Gold Economy Tesla Nse Traders Profit Treasury Digital Assets Sp 500 Bse Sensex Federal Reserve Acc Contraction Raising Nyag Woodside Energy Share Tax Breaks Social Media Hack Fashion Segment Govdeals Aviation Disaster

Filter by:

Trial × MarketWatch Top Stories ×

MarketWatch Top Stories • May 30, 2025

Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers a failure

The unsuccessful outcome of Regeneron’s advanced COPD therapy study led to a significant decline in its stock value, marking the company’s largest drop in over a decade on financia...

Read Full Article →